ES2186501A1 - Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno. - Google Patents

Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno.

Info

Publication number
ES2186501A1
ES2186501A1 ES200002811A ES200002811A ES2186501A1 ES 2186501 A1 ES2186501 A1 ES 2186501A1 ES 200002811 A ES200002811 A ES 200002811A ES 200002811 A ES200002811 A ES 200002811A ES 2186501 A1 ES2186501 A1 ES 2186501A1
Authority
ES
Spain
Prior art keywords
collagen binding
binding domain
growth factor
fibroblastic growth
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200002811A
Other languages
English (en)
Other versions
ES2186501B1 (es
Inventor
Gomez Jose Antonio Andrades
Ratia Jose Becerra
Frederick L Hall
Marcel E Nimni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Malaga
Original Assignee
Universidad de Malaga
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Malaga filed Critical Universidad de Malaga
Priority to ES200002811A priority Critical patent/ES2186501B1/es
Priority to EP01997505A priority patent/EP1357130A1/en
Priority to PCT/ES2001/000449 priority patent/WO2002042331A1/es
Priority to AU2002220756A priority patent/AU2002220756A1/en
Publication of ES2186501A1 publication Critical patent/ES2186501A1/es
Application granted granted Critical
Publication of ES2186501B1 publication Critical patent/ES2186501B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Factor de crecimiento fibroblástico básico con un dominio de unión específico a colágeno. La presente invención describe el diseño genético y la expresión a gran escala en Escherichia coli de un factor de crecimiento fibroblástico básico, con un dominio de unión específico a colágeno, así como su purificación y renaturalización hasta alcanzar su actividad biológica. La principal característica de este factor es la incorporación de un dominio auxiliar aminoacídico modificado, de alta afinidad de unión específica al colágeno, que posibilita su almacenamiento por tiempos prolongados y le permite ser dirigido a lugares específicos donde se precise de su actuación, controlando su liberación y preservando su bioestabilidad. Estas propiedades posibilitan el uso del factor como agente terapéutico, con un papel primordial en la cicatrización de heridas y en otros procesos de reparación tisular.
ES200002811A 2000-11-23 2000-11-23 Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno. Expired - Fee Related ES2186501B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES200002811A ES2186501B1 (es) 2000-11-23 2000-11-23 Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno.
EP01997505A EP1357130A1 (en) 2000-11-23 2001-11-23 Basic fibroblastic growth factor with a specific collagen binding domain
PCT/ES2001/000449 WO2002042331A1 (es) 2000-11-23 2001-11-23 Factor de crecimiento fibroblastico basico con un dominio de union especifico a colageno
AU2002220756A AU2002220756A1 (en) 2000-11-23 2001-11-23 Basic fibroblastic growth factor with a specific collagen binding domain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200002811A ES2186501B1 (es) 2000-11-23 2000-11-23 Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno.

Publications (2)

Publication Number Publication Date
ES2186501A1 true ES2186501A1 (es) 2003-05-01
ES2186501B1 ES2186501B1 (es) 2006-05-16

Family

ID=8495741

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200002811A Expired - Fee Related ES2186501B1 (es) 2000-11-23 2000-11-23 Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno.

Country Status (4)

Country Link
EP (1) EP1357130A1 (es)
AU (1) AU2002220756A1 (es)
ES (1) ES2186501B1 (es)
WO (1) WO2002042331A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073661A1 (fr) * 2005-12-26 2007-07-05 Yantai Zhenghai Bio-Technology Co., Ltd. Matieres de squelette de collagene activees et leurs facteurs speciaux de restauration active fusionnee
ES2342707B1 (es) * 2008-12-31 2011-06-10 Universidad De Malaga Proteina morfogenetica de hueso-2 (bmp-2) con un dominio de union especifico a colageno tipo i, procedimiento de obtencion y aplicaciones.
ES2417705B1 (es) * 2012-01-04 2014-05-27 Centro De Investigación Biomédica En Red En Bioingeniería, Biomateriales Y Nanomedicina (Ciber-Bbn) Péptido biomimético rgd con dominio de afinidad por el colágeno tipo i y sus usos como factor osteogénico.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044938A1 (en) * 1997-04-10 1998-10-15 University Of Southern California Modified proteins which bind extracellular matrix components
WO2000006195A1 (en) * 1998-07-31 2000-02-10 University Of Southern California Targeting pharmaceutical agents to injured tissues
WO2000049159A1 (en) * 1999-02-19 2000-08-24 Terumo Kabushiki Kaisha Collagen-binding physiologically active polypeptide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044938A1 (en) * 1997-04-10 1998-10-15 University Of Southern California Modified proteins which bind extracellular matrix components
WO2000006195A1 (en) * 1998-07-31 2000-02-10 University Of Southern California Targeting pharmaceutical agents to injured tissues
WO2000049159A1 (en) * 1999-02-19 2000-08-24 Terumo Kabushiki Kaisha Collagen-binding physiologically active polypeptide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDRADES, J.A. et al. "A recombinant human TGF-Beta1 fusion protein with collagen-binding domain promotes migration, growth and differentiation of bone marrow mesenchymal cells". EXPERIMENTAL CELL RESEARCH, Vol. 250, 1999, pßginas 485-498. Todo el documento, especialmente pßgina 487, figura 1. *
NISHI, N. et al. "Collagen-binding growth factors: Production and characterization of functional fusion proteins having a collagen-binding domain". PROC. NATL. ACAD. SCI. USA, Vol. 95, junio 1998, pßginas 7018-7023, todo el documento. *

Also Published As

Publication number Publication date
ES2186501B1 (es) 2006-05-16
WO2002042331A1 (es) 2002-05-30
AU2002220756A1 (en) 2002-06-03
EP1357130A1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
RS51898B (sr) Specifični agensi koji vezuju humani angiopoetin-2
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
YU68002A (sh) Modifikovani faktor viii
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
DE69433530D1 (de) Bmp-11 zusammensetzungen
MX2008009493A (es) Peptido novedoso y uso del mismo.
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
DE60334589D1 (de) Verwendung von p43 zur Förderung der Wundheilung
BR9811861A (pt) Polipeptìdeos de fatores de crescimento ligantes de heparina (fclh)
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
DE50015938D1 (de) Polypeptidvarianten mit erhoehter heparin-bindungsfaehigkeit
ATE495247T1 (de) Chromoprotein und fluoroproteine
IL173969A0 (en) Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock
DE69535855D1 (de) Calciumbindende rekombinante antikörper gegen protein c
RS50857B (sr) Konjugati polimera neublastina i postupci za njihovu upotrebu
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
DE60107560D1 (de) Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe
ES2186501A1 (es) Factor de crecimiento fibroblastico basico con un dominio de union especifico a colegeno.
HK1121383A1 (en) Wound healing agent and composition
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
HU0102041D0 (en) Pharmacological compounds which bind to [3h]-gabapentine binding protein
CA2321933A1 (en) Fibronectin peptides-based extracellular matrix for wound healing

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030501

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2186501B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20210302